AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 170 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 8.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $78,000 | -50.0% | 10,245 | -20.1% | 0.00% | -100.0% |
| Q4 2019 | $156,000 | -2.5% | 12,830 | -7.5% | 0.00% | 0.0% |
| Q3 2019 | $160,000 | +11.1% | 13,868 | -4.0% | 0.00% | 0.0% |
| Q2 2019 | $144,000 | -32.1% | 14,450 | -12.3% | 0.00% | 0.0% |
| Q1 2019 | $212,000 | -14.2% | 16,486 | +1.2% | 0.00% | -50.0% |
| Q4 2018 | $247,000 | -35.5% | 16,290 | -14.8% | 0.00% | -33.3% |
| Q3 2018 | $383,000 | -2.0% | 19,130 | -4.6% | 0.00% | 0.0% |
| Q2 2018 | $391,000 | -11.3% | 20,056 | -8.4% | 0.00% | 0.0% |
| Q1 2018 | $441,000 | +31.2% | 21,896 | -13.6% | 0.00% | +50.0% |
| Q4 2017 | $336,000 | -20.8% | 25,339 | +10.3% | 0.00% | -50.0% |
| Q3 2017 | $424,000 | +6.5% | 22,974 | +6.3% | 0.00% | 0.0% |
| Q2 2017 | $398,000 | -23.8% | 21,610 | -6.6% | 0.00% | -20.0% |
| Q1 2017 | $522,000 | -48.2% | 23,141 | -20.1% | 0.01% | -54.5% |
| Q4 2016 | $1,008,000 | +60.3% | 28,962 | +12.8% | 0.01% | +22.2% |
| Q3 2016 | $629,000 | -14.5% | 25,683 | -16.6% | 0.01% | 0.0% |
| Q2 2016 | $736,000 | +2.4% | 30,779 | +0.1% | 0.01% | -10.0% |
| Q1 2016 | $719,000 | -27.7% | 30,742 | -6.7% | 0.01% | -16.7% |
| Q4 2015 | $994,000 | -14.5% | 32,933 | +12.5% | 0.01% | -25.0% |
| Q3 2015 | $1,163,000 | -40.4% | 29,282 | +3.7% | 0.02% | -40.7% |
| Q2 2015 | $1,951,000 | +26.8% | 28,249 | +0.3% | 0.03% | +50.0% |
| Q1 2015 | $1,539,000 | +71.8% | 28,151 | +33.8% | 0.02% | +80.0% |
| Q4 2014 | $896,000 | +40.4% | 21,034 | +5.2% | 0.01% | +25.0% |
| Q3 2014 | $638,000 | +28.6% | 19,991 | -16.5% | 0.01% | +33.3% |
| Q2 2014 | $496,000 | -33.5% | 23,943 | -37.9% | 0.01% | -33.3% |
| Q1 2014 | $746,000 | +175.3% | 38,536 | +245.7% | 0.01% | +125.0% |
| Q4 2013 | $271,000 | -40.6% | 11,147 | -47.5% | 0.00% | -63.6% |
| Q3 2013 | $456,000 | +14.0% | 21,246 | +18.1% | 0.01% | +37.5% |
| Q2 2013 | $400,000 | – | 17,990 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
| Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
| Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
| Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
| Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
| AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
| ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |